Avid Bioservices Inc (CDMO)

[pphmtoolong]

PVL, as Ronald Reagan used to say, "There you go again." I do not agree this year is dead.

As I noted many times before in this forum, "If Abbvie was ready to partner in 2012 before the Phase II NSCLC trial results came out, how much more attractive a partner is Peregrine now. See the following:

1. The Phase III trial is well past the half way point. Steve King suggests mid 2016 for the second Sunrise look-in. At that point we are no longer looking at enrollment data or safety, we should see efficacy data.

2. Research has since established the MOA of Bavituximab in numerous studies, some of them published in bio journals.

3. AstraZeneca is jointly researching Bavi with its immune drugs.

4. A Bavi-Yervoy trial running.

5. A Bavi-opdivo trial launching soon.

6. A Bavi trial in HER-2 negative breast cancer launching soon.

ETC.

We could see a lucrative partnership PR Monday. This year may yet have a lot of life left in it.

GLTA, Especially Bavi-arm Sunrise Patients,

Paul